Kinetic measures of a cerebrospinal fluid (CSF) biomarker test predicted cognitive decline in Parkinson's disease and distinguished it from progressive supranuclear palsy (PSP), an analysis of data ...

(CN) — Proteins in the blood may provide key indicators of the inflammatory process that takes place in the early stages of Parkinson’s disease which is likely to allow for broader clinical trials ...

A small new trial published in the journal Nature Medicine describes what would be two firsts for Parkinson's disease, if they pan out: a diagnostic test and a potential immune-based treatment that ...

The new blood test, researchers hope, will help doctors diagnose Parkinson's disease years before symptoms occur, helping them provide more proactive treatments. Visoot Uthairam via Getty Images ...

Faster CSF alpha-synuclein seeding kinetics predicted cognitive decline in Parkinson's in multiple cohorts. GBA1-associated Parkinson's exhibited quicker seeding kinetics than sporadic Parkinson's ...